OpenCitations
Works that cite this article, indexed by OpenCitations.
The Role of Metformin in Modifying Ferroptosis to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: A Narrative Review
Current Reviews in Clinical and Experimental Pharmacology 20(4) (2025)
Mohammadjavad Sotoudeheian; Reza Azarbad; Seyed-Mohamad-Sadegh Mirahmadi; Navid Farahmandian
Effects of metformin on anthropometric indices and hormones and adipocytokine concentrations in children with overweight or obesity: a systematic review and meta-analysis of randomised controlled trials
Archives of Disease in Childhood 111(6) (2025)
Xenophon Theodoridis; Androniki Papaemmanouil; Niki Papageorgiou; Lydia Chrysoula; Stella Stabouli; Michail Chourdakis
Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis
BMC Gastroenterology 25(1) (2025)
Shehab Yaser; Hatem Yaser; Hazem E. Mohammed; Mohamed Nasser; Mohamed Khalafalla Darwish; Mohamed E. Haseeb; Anas Hussein Heiba; Mohamed Mabrouk Ghonaim; Heba Aboeldahab; Zeyad Bady
The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
European Journal of Pediatrics 182(11) (2023)
Nikolaos Gkiourtzis; Panagiota Michou; Maria Moutafi; Agni Glava; Konstantinos Cheirakis; Aristeidis Christakopoulos; Eleni Vouksinou; Maria Fotoulaki
PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis
Journal of International Medical Research 51(6) (2023)
Zhuo-Ya Zhang; Qi Yan; Wen-Hao Wu; Yuan Zhao; Hua Zhang; Jin Li